Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Beta Bionics, Inc.NASDAQ: BBNX
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments falls 10.4% from a year ago
Short-term investments stood at $169.31M at the end of Q1 FY2026, down 10.4% from a year earlier and down 9.7% from the prior quarter.
Context
- Short-term investments amounted to 55.6% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Short-term investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps falling in the next quarterly balance sheet after a -10.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 187.55M USD
- Year-over-year change
- +156.4%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 187.55M | +156.4% |
| FY2024 | 2024-12-31 | 73.14M | +4.2% |
| FY2023 | 2023-12-31 | 70.18M | — |
| FY2022 | 2022-12-31 | 0 | — |
Short-term Investments vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -10.4% is the 4th highest of 7, against a peer median of -22.9%.
- Short-term investments amounts to 55.6% of total assets for BBNX, versus a peer median of 10.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $842M USD | -52.4% | -15.8% | 13.0% | |
| Jun 2026 | DKK 500M DKK | +0.2% | -64.3% | 0.1% | |
| Mar 2026 | $390.93M USD | +24.1% | -23.1% | 33.9% | |
| Mar 2026 | $169.31M USD | -10.4% | — | 55.6% | |
| Mar 2026 | $81.03M USD | -39.6% | -1.5% | 10.9% | |
| Mar 2026 | $52.64M USD | -6.2% | -11.5% | 19.6% | |
| Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $0 USD | — | — | 0.0% |
| Peer median (excluding BBNX) | — | -22.9% | -15.8% | 10.9% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.